Ramy Farid
Chief Executive Officer chez SCHRÖDINGER, INC.
Fortune : 63 M $ au 31/03/2024
Profil
Ramy Farid occupe le poste de président, directeur général et directeur chez Schrdinger, Inc. Il siège également au conseil d'administration de Nimbus Therapeutics LLC, Morphic Therapeutic, Inc, Nimbus Apollo, Inc et Ajax Therapeutics, Inc. Il a précédemment occupé le poste de professeur adjoint à l'université d'État Rutgers du New Jersey. Il est titulaire d'un doctorat de l'Université de Pennsylvanie et d'un doctorat du California Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2023 | 4 085 495 ( 2,92% ) | 58 M $ | 31/03/2024 | |
SCHRODINGER, INC.
0,29% | 04/03/2024 | 184 432 ( 0,29% ) | 5 M $ | 31/03/2024 |
Postes actifs de Ramy Farid
| Sociétés | Poste | Début |
|---|---|---|
| SCHRÖDINGER, INC. | Chief Executive Officer | 01/01/2017 |
| STRUCTURE THERAPEUTICS INC. | Director/Board Member | 01/04/2019 |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Ajax Therapeutics, Inc.
 Ajax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ajax Therapeutics, Inc. operates as a biomedical company. The company is headquartered in New York, NY. | Director/Board Member | - |
Schrodinger, Inc. (Oregon)
 Schrodinger, Inc. (Oregon) Packaged SoftwareTechnology Services Schrodinger, Inc. is a private company based in Portland, OR. The company develops a drug discovery platform. | President | - |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Director/Board Member | 12/04/2022 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Director/Board Member | - |
Anciens postes connus de Ramy Farid
| Sociétés | Poste | Fin |
|---|---|---|
| MORPHIC HOLDING, INC. | Director/Board Member | 01/06/2019 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director/Board Member | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Ramy Farid
| Rochester Christian University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
| California Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SCHRÖDINGER, INC. | Technology Services |
| MORPHIC HOLDING, INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| Entreprise privées | 7 |
|---|---|
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Health Technology |
Ajax Therapeutics, Inc.
Ajax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ajax Therapeutics, Inc. operates as a biomedical company. The company is headquartered in New York, NY. | Health Technology |
Schrodinger, Inc. (Oregon)
Schrodinger, Inc. (Oregon) Packaged SoftwareTechnology Services Schrodinger, Inc. is a private company based in Portland, OR. The company develops a drug discovery platform. | Technology Services |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
